These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31790893)

  • 1. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
    Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
    Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.
    Sakunrangsit N; Ketchart W
    Eur J Pharmacol; 2020 Feb; 868():172878. PubMed ID: 31863768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation.
    Sakunrangsit N; Kalpongnukul N; Pisitkun T; Ketchart W
    Phytother Res; 2016 Dec; 30(12):1968-1977. PubMed ID: 27530731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance.
    Luo F; Yang J; Yang X; Mi J; Ye T; Li G; Xie Y
    Phytomedicine; 2024 Oct; 133():155945. PubMed ID: 39146878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt/β-catenin pathway in endocrine resistant breast cancer.
    Sakunrangsit N; Ketchart W
    Pharmacol Res; 2019 Dec; 150():104517. PubMed ID: 31693936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer.
    Fiorillo M; Sotgia F; Sisci D; Cappello AR; Lisanti MP
    Oncotarget; 2017 Mar; 8(12):20309-20327. PubMed ID: 28411284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
    Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
    Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
    Xue D; Zhou X; Qiu J
    J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
    Yao Y; Brodie AM; Davidson NE; Kensler TW; Zhou Q
    Breast Cancer Res Treat; 2010 Nov; 124(2):585-91. PubMed ID: 20623181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plumbagin Triggers ER Stress-Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS.
    Huang H; Xie H; Pan Y; Zheng K; Xia Y; Chen W
    Cell Physiol Biochem; 2018; 45(1):267-280. PubMed ID: 29357323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer.
    Chonsut P; Mahalapbutr P; Pradubyat N; Chavasiri W; Wonganan P; Ketchart W
    J Pharm Pharmacol; 2019 Dec; 71(12):1839-1853. PubMed ID: 31588558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
    Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
    Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
    Jordan NJ; Dutkowski CM; Barrow D; Mottram HJ; Hutcheson IR; Nicholson RI; Guichard SM; Gee JM
    Breast Cancer Res; 2014 Jan; 16(1):R12. PubMed ID: 24457069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
    Kawiak A; Domachowska A; Jaworska A; Lojkowska E
    Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.
    Jiang M; Huang O; Zhang X; Xie Z; Shen A; Liu H; Geng M; Shen K
    Molecules; 2013 Jan; 18(1):701-20. PubMed ID: 23299550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells.
    Chaisit S; Jianmongkol S
    Biol Pharm Bull; 2021; 44(9):1239-1246. PubMed ID: 34471052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
    Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
    Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
    Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
    Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.